Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
Bo WangMeng ZhouXing-Li GanYue-Xiang RenYuan-Zhong YangZi-Jin WengXiao-Fang ZhangJie-Xia GuanLu-Ying TangZe-Fang RenPublished in: International journal of clinical oncology (2023)
There was an interaction between H4K16ac and H4K20me3 on the prognosis of breast cancer and the combination of them was a superior prognostic marker compared to the single one.